| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |